#Istat troponin procedure portable

High, unnecessary costs result from the admission of patients with a low probability of acute coronary artery disease, as well as from releasing patients with a missed acute myocardial infarction (AMI), which can result in a decrease in the patient’s quality of life or even death and, subsequently, medical malpractice claims. Hospital expenses, however, are not the only costs incurred. In 1999, the cost of hospitalization for cardiovascular problems among Medicare beneficiaries totaled $26.3 billion. 4 The CDC and National Center for Chronic Disease Prevention and Health Promotion reported that in 2003, the cost of heart disease and stroke in the United States was projected to be $351 billion: $209 billion for health care expenditures and $142 billion for lost productivity from death and disability. The American Heart Association estimates the cost of cardiovascular diseases in the United States for 2004 at $368.4 billion. Some of these will likely be one of the almost 6 million annual hospitalizations resulting from cardiovascular disease. The CDC notes, “Much of the burden of heart disease and stroke could be eliminated by reducing their major risk factors: high blood pressure, high blood cholesterol, tobacco use, diabetes, physical inactivity, and poor nutrition.” Patients may be able to control these factors with diet and behavior, or they may require medical aid.

#Istat troponin procedure portable

The new i-STAT 10-Minute Cardiac Troponin I (cTnI) Test cartridge (below) is designed to run with the company’s portable analyzer and deliver test results in under 30 minutes.

Information from the CDC and the National Center for Chronic Disease Prevention and Health Promotion indicates that 10 million people are disabled as a result. According to the Centers for Disease Control and Prevention (CDC), approximately 61 million Americans, nearly a quarter of the population, live with the effects of stroke or heart disease. Of course, not all those suffering from cardiovascular disease will die immediately. 1 Together, these two diseases, which make up the principal components of cardiovascular disease, account for roughly one third of all deaths in the United States. 2 Yet, despite the decline, heart disease remains the nation’s leading cause of death.Ĭerebrovascular disease, whose major event is usually a stroke, is the third-leading killer, responsible for more than 160,000 deaths in the United States in 2001, or 6.8%. 1 This was down from 1999, when it killed more than 725,000 Americans and accounted for 30.3% of all deaths. In 2001, heart disease killed more than 700,000 people in the United States, accounting for 29% of all deaths. The i-STAT Analyzer (left) is small enough to be brought bedside. Other studies have already shown a cost savings to hospitals. Shipp, MD, i-STAT’s vice president of Medical Affairs, says that data are expected to indicate trending and significant results in improved patient outcomes. Though studies are still under way, Gregory W.

The i-STAT 10-Minute Cardiac Troponin I (cTnI) Test, which delivers specific, sensitive results within 10 minutes, received FDA approval in the fall and is now available to hospitals and other facilities where patients present with chest pain. Knowing this, i-STAT Corp of East Windsor, NJ developed a point-of-care test that avoids existing compromises in the market.

Guidelines published in the past few years have recognized this and modified recommendations accordingly, encouraging the use of troponin tests that deliver results in under an hour. The result: more lives saved, better care for the sick patient, and less cost for the well patient and the hospital. Fast, accurate testing can help doctors make an earlier diagnosis for patients presenting in the emergency room with chest pain. Cardiovascular disease is the leading cause of death in the United States, costing not only lives but also billions of dollars per year.